These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7840598)

  • 1. Antimicrobial susceptibilities of clinical isolates of Acinetobacter baumannii from Singapore.
    Kuah BG; Kumarasinghe G; Doran J; Chang HR
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2502-3. PubMed ID: 7840598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibility of clinical isolates of Acinetobacter baumannii.
    Shi ZY; Liu PY; Lau Y; Lin Y; Hu BS; Shir J-M
    Diagn Microbiol Infect Dis; 1996 Feb; 24(2):81-5. PubMed ID: 9147913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
    Zhao C; Xie W; Zhang W; Ye Z; Wu H
    Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations.
    Marques MB; Brookings ES; Moser SA; Sonke PB; Waites KB
    Antimicrob Agents Chemother; 1997 May; 41(5):881-5. PubMed ID: 9145838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species.
    Suh B; Shapiro T; Jones R; Satishchandran V; Truant AL
    Diagn Microbiol Infect Dis; 1995 Feb; 21(2):111-4. PubMed ID: 7628190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
    Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
    Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
    Henwood CJ; Gatward T; Warner M; James D; Stockdale MW; Spence RP; Towner KJ; Livermore DM; Woodford N
    J Antimicrob Chemother; 2002 Mar; 49(3):479-87. PubMed ID: 11864948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of beta-lactams against Acinetobacter genospecies as determined by agar dilution and E-test MIC methods.
    Visalli MA; Jacobs MR; Moore TD; Renzi FA; Appelbaum PC
    Antimicrob Agents Chemother; 1997 Apr; 41(4):767-70. PubMed ID: 9087486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Acinetobacter species.
    Seifert H; Baginski R; Schulze A; Pulverer G
    Antimicrob Agents Chemother; 1993 Apr; 37(4):750-3. PubMed ID: 8494371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evolution of antimicrobial susceptibility of Acinetobacter baumannii clinical isolates].
    López-Hernández S; Alarcón T; López-Brea M
    Rev Esp Quimioter; 2000 Dec; 13(4):394-400. PubMed ID: 11498706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the VITEK 2 system for the identification and susceptibility testing of three species of nonfermenting gram-negative rods frequently isolated from clinical samples.
    Joyanes P; del Carmen Conejo M; Martínez-Martínez L; Perea EJ
    J Clin Microbiol; 2001 Sep; 39(9):3247-53. PubMed ID: 11526158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2905-7. PubMed ID: 7695281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of beta-lactam agents and beta-lactamase inhibitors in clinical isolates of Acinetobacter baumannii].
    López-Hernández S; Alarcón T; Delgado T; de Las Cuevas MC; López-Brea M
    Rev Esp Quimioter; 1999 Jun; 12(2):140-3. PubMed ID: 10562675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong.
    Ling TK; Ying CM; Lee CC; Liu ZK
    Med Princ Pract; 2005; 14(5):338-41. PubMed ID: 16103700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
    Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
    Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii].
    Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P
    Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of resistance among clinical isolates of Acinetobacter over a 6-year period.
    Ruiz J; Núñez ML; Pérez J; Simarro E; Martínez-Campos L; Gómez J
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):292-5. PubMed ID: 10385020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility testing of Acinetobacter spp. by NCCLS broth microdilution and disk diffusion methods.
    Swenson JM; Killgore GE; Tenover FC
    J Clin Microbiol; 2004 Nov; 42(11):5102-8. PubMed ID: 15528702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan.
    Hsueh SC; Lee YJ; Huang YT; Liao CH; Tsuji M; Hsueh PR
    J Antimicrob Chemother; 2019 Feb; 74(2):380-386. PubMed ID: 30357343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of clinical Acinetobacter spp. strains.
    Hostacká A; Klokocníková L
    Folia Microbiol (Praha); 2002; 47(5):579-82. PubMed ID: 12503407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.